Frontiers in Pharmacology has organized a series of special edition Research Topics highlighting the diversity of research performed globally and welcoming insights from internationally recognized researchers in the field.
Global alliance is the cornerstone of scientific advancement. Such collaborations help in robust solving of a problem with diverse scientific perspectives and thoughts making a meaningful scientific outcome.
The Research Topic aims to target the recent progress made across the entire breadth of Inflammation Pharmacology worldwide, emphasizing advancements in drug development to inflammation-related diseases and reflecting on the future challenges faced by researchers across borders.
We strongly encourage the submission of manuscripts consisting of both original research and review articles. Also, we will welcome the submission article types within the scope of the Inflammation Pharmacology including Brief Research Report, Correction, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Opinion, Perspective, Technology and Code.
Please note, only manuscripts with reports on chemically defined pharmacological agents will be accepted. Manuscripts with reports on plant extracts or other chemically undefined compounds will not be accepted for review.
Frontiers in Pharmacology has organized a series of special edition Research Topics highlighting the diversity of research performed globally and welcoming insights from internationally recognized researchers in the field.
Global alliance is the cornerstone of scientific advancement. Such collaborations help in robust solving of a problem with diverse scientific perspectives and thoughts making a meaningful scientific outcome.
The Research Topic aims to target the recent progress made across the entire breadth of Inflammation Pharmacology worldwide, emphasizing advancements in drug development to inflammation-related diseases and reflecting on the future challenges faced by researchers across borders.
We strongly encourage the submission of manuscripts consisting of both original research and review articles. Also, we will welcome the submission article types within the scope of the Inflammation Pharmacology including Brief Research Report, Correction, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Opinion, Perspective, Technology and Code.
Please note, only manuscripts with reports on chemically defined pharmacological agents will be accepted. Manuscripts with reports on plant extracts or other chemically undefined compounds will not be accepted for review.
